Global Single-Photon Emission Computed Tomography (SPECT) Market Research Report 2023
Global Single-Photon Emission Computed Tomography (SPECT) Market Overview:
Global Single-Photon Emission Computed Tomography (SPECT) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Single-Photon Emission Computed Tomography (SPECT) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Single-Photon Emission Computed Tomography (SPECT) Market
The Single-Photon Emission Computed Tomography (SPECT) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Single-Photon Emission Computed Tomography (SPECT) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Single-Photon Emission Computed Tomography (SPECT) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Single-Photon Emission Computed Tomography (SPECT) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Single-Photon Emission Computed Tomography (SPECT) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Single-Photon Emission Computed Tomography (SPECT) Market Segmentation
Global Single-Photon Emission Computed Tomography (SPECT) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Single-Photon Emission Computed Tomography (SPECT) market has been segmented into:
Standalone SPECT
Hybrid SPECT
By Application, Single-Photon Emission Computed Tomography (SPECT) market has been segmented into:
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Single-Photon Emission Computed Tomography (SPECT) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Single-Photon Emission Computed Tomography (SPECT) market.
Top Key Players Covered in Single-Photon Emission Computed Tomography (SPECT) market are:
Philips Healthcare
Bruker
Esaote
TriFoil Imaging
Invicro
MR Solutions
Siemens Healthineers
Digirad Corporation
Toshiba Medical (Canon)
LambdaSpect
GE Healthcare
Mediso Medical Imaging Systems
Objective to buy this Report:
1. Single-Photon Emission Computed Tomography (SPECT) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Single-Photon Emission Computed Tomography (SPECT) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Single-Photon Emission Computed Tomography (SPECT) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Single-Photon Emission Computed Tomography (SPECT) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Single-Photon Emission Computed Tomography (SPECT) Market
The Single-Photon Emission Computed Tomography (SPECT) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Single-Photon Emission Computed Tomography (SPECT) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Single-Photon Emission Computed Tomography (SPECT) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Single-Photon Emission Computed Tomography (SPECT) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Single-Photon Emission Computed Tomography (SPECT) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Single-Photon Emission Computed Tomography (SPECT) Market Segmentation
Global Single-Photon Emission Computed Tomography (SPECT) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Single-Photon Emission Computed Tomography (SPECT) market has been segmented into:
Standalone SPECT
Hybrid SPECT
By Application, Single-Photon Emission Computed Tomography (SPECT) market has been segmented into:
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Single-Photon Emission Computed Tomography (SPECT) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Single-Photon Emission Computed Tomography (SPECT) market.
Top Key Players Covered in Single-Photon Emission Computed Tomography (SPECT) market are:
Philips Healthcare
Bruker
Esaote
TriFoil Imaging
Invicro
MR Solutions
Siemens Healthineers
Digirad Corporation
Toshiba Medical (Canon)
LambdaSpect
GE Healthcare
Mediso Medical Imaging Systems
Objective to buy this Report:
1. Single-Photon Emission Computed Tomography (SPECT) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Single-Photon Emission Computed Tomography (SPECT) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY TYPE
5.1 Single-Photon Emission Computed Tomography (SPECT) Market Overview Snapshot and Growth Engine
5.2 Single-Photon Emission Computed Tomography (SPECT) Market Overview
5.3 Standalone SPECT
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Standalone SPECT: Geographic Segmentation
5.4 Hybrid SPECT
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hybrid SPECT: Geographic Segmentation
CHAPTER 6: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY APPLICATION
6.1 Single-Photon Emission Computed Tomography (SPECT) Market Overview Snapshot and Growth Engine
6.2 Single-Photon Emission Computed Tomography (SPECT) Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Diagnostic Imaging Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Imaging Centers: Geographic Segmentation
6.5 Ambulatory Surgical Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Ambulatory Surgical Centers: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Single-Photon Emission Computed Tomography (SPECT) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Single-Photon Emission Computed Tomography (SPECT) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Single-Photon Emission Computed Tomography (SPECT) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PHILIPS HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BRUKER
7.4 ESAOTE
7.5 TRIFOIL IMAGING
7.6 INVICRO
7.7 MR SOLUTIONS
7.8 SIEMENS HEALTHINEERS
7.9 DIGIRAD CORPORATION
7.10 TOSHIBA MEDICAL (CANON)
7.11 LAMBDASPECT
7.12 GE HEALTHCARE
7.13 MEDISO MEDICAL IMAGING SYSTEMS
CHAPTER 8: GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Standalone SPECT
8.2.2 Hybrid SPECT
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Diagnostic Imaging Centers
8.3.3 Ambulatory Surgical Centers
CHAPTER 9: NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Standalone SPECT
9.4.2 Hybrid SPECT
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Diagnostic Imaging Centers
9.5.3 Ambulatory Surgical Centers
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Standalone SPECT
10.4.2 Hybrid SPECT
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Diagnostic Imaging Centers
10.5.3 Ambulatory Surgical Centers
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Standalone SPECT
11.4.2 Hybrid SPECT
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Diagnostic Imaging Centers
11.5.3 Ambulatory Surgical Centers
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Standalone SPECT
12.4.2 Hybrid SPECT
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Diagnostic Imaging Centers
12.5.3 Ambulatory Surgical Centers
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Standalone SPECT
13.4.2 Hybrid SPECT
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Diagnostic Imaging Centers
13.5.3 Ambulatory Surgical Centers
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY TYPE
5.1 Single-Photon Emission Computed Tomography (SPECT) Market Overview Snapshot and Growth Engine
5.2 Single-Photon Emission Computed Tomography (SPECT) Market Overview
5.3 Standalone SPECT
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Standalone SPECT: Geographic Segmentation
5.4 Hybrid SPECT
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hybrid SPECT: Geographic Segmentation
CHAPTER 6: SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY APPLICATION
6.1 Single-Photon Emission Computed Tomography (SPECT) Market Overview Snapshot and Growth Engine
6.2 Single-Photon Emission Computed Tomography (SPECT) Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Diagnostic Imaging Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Imaging Centers: Geographic Segmentation
6.5 Ambulatory Surgical Centers
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Ambulatory Surgical Centers: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Single-Photon Emission Computed Tomography (SPECT) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Single-Photon Emission Computed Tomography (SPECT) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Single-Photon Emission Computed Tomography (SPECT) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PHILIPS HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BRUKER
7.4 ESAOTE
7.5 TRIFOIL IMAGING
7.6 INVICRO
7.7 MR SOLUTIONS
7.8 SIEMENS HEALTHINEERS
7.9 DIGIRAD CORPORATION
7.10 TOSHIBA MEDICAL (CANON)
7.11 LAMBDASPECT
7.12 GE HEALTHCARE
7.13 MEDISO MEDICAL IMAGING SYSTEMS
CHAPTER 8: GLOBAL SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Standalone SPECT
8.2.2 Hybrid SPECT
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Diagnostic Imaging Centers
8.3.3 Ambulatory Surgical Centers
CHAPTER 9: NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Standalone SPECT
9.4.2 Hybrid SPECT
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Diagnostic Imaging Centers
9.5.3 Ambulatory Surgical Centers
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Standalone SPECT
10.4.2 Hybrid SPECT
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Diagnostic Imaging Centers
10.5.3 Ambulatory Surgical Centers
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Standalone SPECT
11.4.2 Hybrid SPECT
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Diagnostic Imaging Centers
11.5.3 Ambulatory Surgical Centers
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Standalone SPECT
12.4.2 Hybrid SPECT
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Diagnostic Imaging Centers
12.5.3 Ambulatory Surgical Centers
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Standalone SPECT
13.4.2 Hybrid SPECT
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Diagnostic Imaging Centers
13.5.3 Ambulatory Surgical Centers
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET COMPETITIVE RIVALRY
TABLE 005. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET THREAT OF NEW ENTRANTS
TABLE 006. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET THREAT OF SUBSTITUTES
TABLE 007. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY TYPE
TABLE 008. STANDALONE SPECT MARKET OVERVIEW (2016-2028)
TABLE 009. HYBRID SPECT MARKET OVERVIEW (2016-2028)
TABLE 010. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY APPLICATION
TABLE 011. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 012. DIAGNOSTIC IMAGING CENTERS MARKET OVERVIEW (2016-2028)
TABLE 013. AMBULATORY SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 016. N SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 019. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 022. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 025. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 028. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 029. PHILIPS HEALTHCARE: SNAPSHOT
TABLE 030. PHILIPS HEALTHCARE: BUSINESS PERFORMANCE
TABLE 031. PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 032. PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. BRUKER: SNAPSHOT
TABLE 033. BRUKER: BUSINESS PERFORMANCE
TABLE 034. BRUKER: PRODUCT PORTFOLIO
TABLE 035. BRUKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. ESAOTE: SNAPSHOT
TABLE 036. ESAOTE: BUSINESS PERFORMANCE
TABLE 037. ESAOTE: PRODUCT PORTFOLIO
TABLE 038. ESAOTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. TRIFOIL IMAGING: SNAPSHOT
TABLE 039. TRIFOIL IMAGING: BUSINESS PERFORMANCE
TABLE 040. TRIFOIL IMAGING: PRODUCT PORTFOLIO
TABLE 041. TRIFOIL IMAGING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. INVICRO: SNAPSHOT
TABLE 042. INVICRO: BUSINESS PERFORMANCE
TABLE 043. INVICRO: PRODUCT PORTFOLIO
TABLE 044. INVICRO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. MR SOLUTIONS: SNAPSHOT
TABLE 045. MR SOLUTIONS: BUSINESS PERFORMANCE
TABLE 046. MR SOLUTIONS: PRODUCT PORTFOLIO
TABLE 047. MR SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. SIEMENS HEALTHINEERS: SNAPSHOT
TABLE 048. SIEMENS HEALTHINEERS: BUSINESS PERFORMANCE
TABLE 049. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 050. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. DIGIRAD CORPORATION: SNAPSHOT
TABLE 051. DIGIRAD CORPORATION: BUSINESS PERFORMANCE
TABLE 052. DIGIRAD CORPORATION: PRODUCT PORTFOLIO
TABLE 053. DIGIRAD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. TOSHIBA MEDICAL (CANON): SNAPSHOT
TABLE 054. TOSHIBA MEDICAL (CANON): BUSINESS PERFORMANCE
TABLE 055. TOSHIBA MEDICAL (CANON): PRODUCT PORTFOLIO
TABLE 056. TOSHIBA MEDICAL (CANON): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. LAMBDASPECT: SNAPSHOT
TABLE 057. LAMBDASPECT: BUSINESS PERFORMANCE
TABLE 058. LAMBDASPECT: PRODUCT PORTFOLIO
TABLE 059. LAMBDASPECT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. GE HEALTHCARE: SNAPSHOT
TABLE 060. GE HEALTHCARE: BUSINESS PERFORMANCE
TABLE 061. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 062. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. MEDISO MEDICAL IMAGING SYSTEMS: SNAPSHOT
TABLE 063. MEDISO MEDICAL IMAGING SYSTEMS: BUSINESS PERFORMANCE
TABLE 064. MEDISO MEDICAL IMAGING SYSTEMS: PRODUCT PORTFOLIO
TABLE 065. MEDISO MEDICAL IMAGING SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET COMPETITIVE RIVALRY
TABLE 005. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET THREAT OF NEW ENTRANTS
TABLE 006. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET THREAT OF SUBSTITUTES
TABLE 007. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY TYPE
TABLE 008. STANDALONE SPECT MARKET OVERVIEW (2016-2028)
TABLE 009. HYBRID SPECT MARKET OVERVIEW (2016-2028)
TABLE 010. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY APPLICATION
TABLE 011. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 012. DIAGNOSTIC IMAGING CENTERS MARKET OVERVIEW (2016-2028)
TABLE 013. AMBULATORY SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 016. N SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 019. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 022. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 025. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY APPLICATION (2016-2028)
TABLE 028. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET, BY COUNTRY (2016-2028)
TABLE 029. PHILIPS HEALTHCARE: SNAPSHOT
TABLE 030. PHILIPS HEALTHCARE: BUSINESS PERFORMANCE
TABLE 031. PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 032. PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. BRUKER: SNAPSHOT
TABLE 033. BRUKER: BUSINESS PERFORMANCE
TABLE 034. BRUKER: PRODUCT PORTFOLIO
TABLE 035. BRUKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. ESAOTE: SNAPSHOT
TABLE 036. ESAOTE: BUSINESS PERFORMANCE
TABLE 037. ESAOTE: PRODUCT PORTFOLIO
TABLE 038. ESAOTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. TRIFOIL IMAGING: SNAPSHOT
TABLE 039. TRIFOIL IMAGING: BUSINESS PERFORMANCE
TABLE 040. TRIFOIL IMAGING: PRODUCT PORTFOLIO
TABLE 041. TRIFOIL IMAGING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. INVICRO: SNAPSHOT
TABLE 042. INVICRO: BUSINESS PERFORMANCE
TABLE 043. INVICRO: PRODUCT PORTFOLIO
TABLE 044. INVICRO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. MR SOLUTIONS: SNAPSHOT
TABLE 045. MR SOLUTIONS: BUSINESS PERFORMANCE
TABLE 046. MR SOLUTIONS: PRODUCT PORTFOLIO
TABLE 047. MR SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. SIEMENS HEALTHINEERS: SNAPSHOT
TABLE 048. SIEMENS HEALTHINEERS: BUSINESS PERFORMANCE
TABLE 049. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 050. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. DIGIRAD CORPORATION: SNAPSHOT
TABLE 051. DIGIRAD CORPORATION: BUSINESS PERFORMANCE
TABLE 052. DIGIRAD CORPORATION: PRODUCT PORTFOLIO
TABLE 053. DIGIRAD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. TOSHIBA MEDICAL (CANON): SNAPSHOT
TABLE 054. TOSHIBA MEDICAL (CANON): BUSINESS PERFORMANCE
TABLE 055. TOSHIBA MEDICAL (CANON): PRODUCT PORTFOLIO
TABLE 056. TOSHIBA MEDICAL (CANON): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. LAMBDASPECT: SNAPSHOT
TABLE 057. LAMBDASPECT: BUSINESS PERFORMANCE
TABLE 058. LAMBDASPECT: PRODUCT PORTFOLIO
TABLE 059. LAMBDASPECT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. GE HEALTHCARE: SNAPSHOT
TABLE 060. GE HEALTHCARE: BUSINESS PERFORMANCE
TABLE 061. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 062. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. MEDISO MEDICAL IMAGING SYSTEMS: SNAPSHOT
TABLE 063. MEDISO MEDICAL IMAGING SYSTEMS: BUSINESS PERFORMANCE
TABLE 064. MEDISO MEDICAL IMAGING SYSTEMS: PRODUCT PORTFOLIO
TABLE 065. MEDISO MEDICAL IMAGING SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY TYPE
FIGURE 012. STANDALONE SPECT MARKET OVERVIEW (2016-2028)
FIGURE 013. HYBRID SPECT MARKET OVERVIEW (2016-2028)
FIGURE 014. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY APPLICATION
FIGURE 015. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 016. DIAGNOSTIC IMAGING CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 017. AMBULATORY SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY TYPE
FIGURE 012. STANDALONE SPECT MARKET OVERVIEW (2016-2028)
FIGURE 013. HYBRID SPECT MARKET OVERVIEW (2016-2028)
FIGURE 014. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY APPLICATION
FIGURE 015. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 016. DIAGNOSTIC IMAGING CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 017. AMBULATORY SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET OVERVIEW BY COUNTRY (2016-2028)
